Preclinical development of tacrolimus for radiation cystitis
Ended Project Grant Awarded Last action
- Award ID
- R44DK102247
- Recipient
-
Lipella Pharmaceuticals Inc. UEI JBVNWFNEEV59
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,499,494
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$528 | |
| Amendment | -$528 | |
| Amendment | $0 | |
| Amendment | $629,914 | |
| Amendment | $648,461 | |
| Original award | $222,176 |
Quick answers
Who received award R44DK102247?
R44DK102247 was awarded to Lipella Pharmaceuticals Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on May 12, 2014.
How much is award R44DK102247 worth?
$1,499,494 has been obligated on R44DK102247.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award